Menerba, an oral, estrogen receptor beta (ER-b) selective drug candidate is developed to treat vasomotor symptoms (hot flashes) associated with menopause, which is manufactured from botanical sources. The
The first patent covers a class of compounds that combine elements of diketopiperazines and methylphenidate derivatives, while the second patent is directed to novel derivatives of methylphenidate (Ritalin).
The company recently filed its first provisional patent application for use of anti-adhesion molecule therapies to treat FIV infections, and has identified three candidate antibodies that are likely
Both the companies will discover, develop and commercialize synthetic siRNA directed towards an undisclosed target for the treatment of glaucoma. Once Sylentis exercises this option, Alnylam will be
The two companies entered into a drug discovery and development collaboration on May 2008 with an aim to discover new treatments for neuropsychiatric disorders. PsychoGenics evaluated a library
The cream is helpful in providing relief to burning, itching and pain caused in different types of skin conditions, including atopic dermatitis (eczema), allergic contact dermatitis and radiation
The agreement lays emphasis on identification of compounds known as ‘correctors’ which are believed to aid in the ability of the malfunctioning CFTR protein found in CF patients
The companies entered the $1.1bn collaboration agreement in August 2010, which covers five programs. Under the collaboration, the two key programs were pertaining to oncology and the third
INC Research intends to offer biopharmaceutical customers an integrated suite of tools to increase decision-making speed, efficiency and flexibility. In addition, the collaboration would help in risk management,
The new Symmetry-adapted perturbation theory (SAPT) helps gain further insights into interactions between molecules including those between a drug and its target, rdmag.com reported. The computer program generated
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.